Target-controlled infusion and population pharmacokinetics of landiolol hydrochloride in patients with peripheral arterial disease
Takayuki Kunisawa,1 Akio Yamagishi,2 Manabu Suno,3 Susumu Nakade,4 Naoki Honda,4 Atsushi Kurosawa,2 Ami Sugawara,2 Yoshikazu Tasaki,5 Hiroshi Iwasaki2 1Surgical Operation Department, Asahikawa Medical University Hospital, Asahikawa, Japan; 2Department of Anesthesiology and Critical Care Medicine,...
Main Authors: | Kunisawa T, Yamagishi A, Suno M, Nakade S, Honda N, Kurosawa A, Sugawara A, Tasaki Y, Iwasaki H |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-01-01
|
Series: | Therapeutics and Clinical Risk Management |
Online Access: | http://www.dovepress.com/target-controlled-infusion-and-population-pharmacokinetics-of-landiolo-peer-reviewed-article-TCRM |
Similar Items
-
Landiolol hydrochloride for prevention of atrial fibrillation during esophagectomy: a randomized controlled trial
by: Yoshitaka Aoki, et al.
Published: (2020-05-01) -
Evaluating the Therapeutic Efficacy and Safety of Landiolol Hydrochloride for Management of Arrhythmia in Critical Settings: Review of the Literature
by: Matsuishi Y, et al.
Published: (2020-04-01) -
Population pharmacokinetics of olprinone in healthy male volunteers
by: Kunisawa T, et al.
Published: (2014-03-01) -
Safety and Efficacy of Low-Dose Continuous Infusion of Landiolol, an Ultra-Short-Acting β-blocker, in Cardiac Surgery
by: Manabu Sato, MD, et al.
Published: (2011-01-01) -
Efficacy and safety of cardioversion with continuous landiolol infusion for atrial tachyarrhythmia in an inflammatory state caused by volvulus in a child with TARP syndrome and postoperative tetralogy of Fallot
by: Kenji Miyamoto, et al.
Published: (2018-08-01)